NCT02087878View on ClinicalTrials.gov

A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell Lymphoma

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

March 31, 2014

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Crohn's DiseaseUlcerative Colitis (UC)Hepatosplenic T-Cell Lymphoma
Trial Locations (1)

56124

AOU Pisana /ID# 208952, Pisa

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY

NCT02087878 - A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell Lymphoma | Biotech Hunter | Biotech Hunter